APPLICATION
ANDA064207
TYPE
ANDA
ORIGINAL APPROVAL
1998-02-18
LATEST ACTION
2000-12-08
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Discontinued
Products
CEFACLORDiscontinued
CEFACLOR EQ 375MG BASE/5ML · FOR SUSPENSION · ORAL
Approval history
2000-12-08Manufacturing (CMC) · Supplement 5AP
1999-05-03Labeling · Supplement 4AP
1999-03-05Manufacturing (CMC) · Supplement 3AP
1999-02-19Manufacturing (CMC) · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.